LifeMD, Inc. (LFMD)

Market price: $2.22

1 valuation method

How each method works

EV / Revenue: $5.46 to $10.28 (midpoint $8.09)

Values the whole business at a peer multiple of sales — used when earnings are thin, volatile, or not yet meaningful, so revenue is the most reliable yardstick.

How it’s calculated
We multiply the company's last-twelve-month revenue by the range of EV/Revenue multiples its peer group trades at, subtract net debt and any minority interests or preferred stock ranking ahead of common shareholders, and divide by shares outstanding for a per-share range.
Why it fits this industry
When profits are thin, volatile, or still to come, revenue is the most dependable figure a company reports — this method values the business on the scale of what it actually sells.
Reading this bar
The bar is the per-share value range this method implies: a conservative low, a central estimate, and an optimistic high. If the current price sits below the bar, the market is pricing the shares below what this method's inputs suggest; if it sits above, the market is pricing them higher. No single bar is a verdict — methods disagree for good reasons, so read the whole field together. A pound of revenue is worth more at a high margin than a low one, so the peer group here is narrowed to companies earning a similar margin wherever enough of them exist. Where too few do, the bar falls back to the wider group and is the bluntest of the multiples — weigh it alongside the earnings-based bars.

EV / Revenue = (1.40/2.06/2.61)× revenue 191,592,458 ≈ 268,085,484.87/394,565,100.17/500,484,441.62 (enterprise_value); enterprise_value -> per share: equity (263,312,357.87/389,791,973.17/495,711,314.62) / 48,200,837 shares [EV bridge: minus net debt 2,719,169, minus minority interest & preferred 2,053,958]

5 methods not shown

Limited data — fewer than three valuation methods could be formed for this company; showing every method we can stand behind.